We demonstrated that, in contrast to classical opioid receptors, ACKR3 will not cause classical G protein signaling and is not modulated from the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists such as naloxone. Alternatively, we recognized that LIH383, an ACKR3-selective subnanomolar https://deborahl592orm6.eqnextwiki.com/user